Literature DB >> 3037010

Conservation in vivo of protease cleavage sites in antigenic sites of poliovirus.

P D Minor, M Ferguson, A Phillips, D I Magrath, A Huovilainen, T Hovi.   

Abstract

Polioviruses possess three major antigenic sites which have been located chemically and structurally on the particle. One of these sites, designated site 1, is strongly immunodominant for serotype 3, but highly immunorecessive for type 1. We report that monoclonal antibodies directed against site 1 of type 1 poliovirus may be isolated by an altered route of immunization of the donor mice. Site 1 is shown to be highly variable for type 1, but highly conserved for type 3 poliovirus, although the converse would be predicted from their immunodominance. The evidence presented suggests that the antigenic conservation is associated with a strong selective pressure for a proteolytic cleavage site within site 1 of type 3. As proteolytic cleavage results in the loss of the antigenicity of site 1 the presence of the cleavage site in a virus replicating in the gut in the presence of proteases would protect the virus from neutralizing antibodies directed against uncleaved site 1. The conservation of the site in type 3 is thus consistent with the view that site 1 is a significant target of a human as well as a murine immune response against type 3.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037010     DOI: 10.1099/0022-1317-68-7-1857

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis.

Authors:  K Wiegers; R Dernick
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

2.  Intestinal trypsin can significantly modify antigenic properties of polioviruses: implications for the use of inactivated poliovirus vaccine.

Authors:  M Roivainen; T Hovi
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

3.  Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

Authors:  J Martín; G Dunn; R Hull; V Patel; P D Minor
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

4.  Protease cleavage sites in HIV-1 gp120 recognized by antigen processing enzymes are conserved and located at receptor binding sites.

Authors:  Bin Yu; Dora P A J Fonseca; Sara M O'Rourke; Phillip W Berman
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

5.  Antigenic modification of polioviruses by host proteolytic enzymes.

Authors:  M Roivainen; A Huovilainen; T Hovi
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  Selective cleavage by trypsin of the capsid protein VP1 of type 3 poliovirus results in improved sorting of cell bound virions.

Authors:  L Piirainen; A Airaksinen; T Hovi; M Roivainen
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Three-dimensional model of the capsid proteins of two biologically different Theiler virus strains: clustering of amino acid difference identifies possible locations of immunogenic sites on the virion.

Authors:  D C Pevear; M Luo; H L Lipton
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Three-dimensional structure of poliovirus serotype 1 neutralizing determinants.

Authors:  G S Page; A G Mosser; J M Hogle; D J Filman; R R Rueckert; M Chow
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Addition of a foreign oligopeptide to the major capsid protein of poliovirus.

Authors:  F Colbère-Garapin; C Christodoulou; R Crainic; A C Garapin; A Candrea
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

10.  Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice.

Authors:  D K Bodkin; M L Nibert; B N Fields
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.